{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:13:01Z","timestamp":1777093981249,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016348","name":"Kyowa Kirin Pharmaceutical Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>X-linked hypophosphataemia (XLH) is a rare genetic condition passed on through the X chromosome which causes multiple symptoms including weakened teeth, bones, and muscles. Due to the rarity of the condition, little is known about the health outcomes as reported by people with the disease. The objectives of this study were threefold: to characterise key patient reported outcome measures (PROMs) in adults with XLH, to identify clusters of symptom-severity groups based on PROMs, and to analyse the longitudinal progression of available PROMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 48 participants from the Rare and Undiagnosed Diseases cohort Study (RUDY) was used to analyse both cross-sectional and longitudinal patient-reported outcomes. We analysed data for health-related quality of life (HRQL): EuroQol 5 dimensions-5 levels (EQ-5D-5L), Short-form 36 (SF-36) Physical Component Score (PCS), and SF-36 Mental Component Score (MCS), sleep: Pittsburgh sleep quality index (PSQI) and Epworth Sleepiness scale (ESS), fatigue: Fatigue Severity Scale (FSS) and Functional assessment of chronic illness therapy-fatigue (FACIT-F), pain: Short form McGill pain questionnaire version 2 (SF-MPQ-2) and PainDETECT, and mental well-being: Hospital anxiety and depression scale (HADS) anxiety and depression. Summary statistics, tests of mean differences, mixed-effects models, and cluster analysis were used to describe and examine the various health dimensions of individuals with XLH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall mean scores were EQ-5D-5L\u2009=\u20090.65, SF-36-PCS\u2009=\u200932.7, and SF-36-MCS\u2009=\u200948.4 for HRQL, ESS\u2009=\u20095.9 and PSQI\u2009=\u20098.9 for sleep, FSS\u2009=\u200932.8 and FACIT-F\u2009=\u2009104.4 for fatigue, SF-MPQ-2\u2009=\u20091.9 for pain, and HADS-depression\u2009=\u20094.7 and HADS-anxiety\u2009=\u20096.2 for mental well-being. 7% reported neuropathic pain (PainDETECT). Whilst many adults with XLH reported good outcomes, extreme or severe problems were reported across all outcomes. Cluster analysis identified that adults with XLH could be divided into two distinct groups, one reporting worse (35.3%) and the other better outcomes (64.7%) (less pain, fatigue, depression, and higher levels of sleep). Longitudinal analysis showed that FACIT-F and HADS-anxiety scores worsened slightly over two years with statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) time coefficients (b\u2009=\u2009\u2009\u2212\u20092.135 and b\u2009=\u20090.314, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although about two thirds of adult participants of the RUDY cohort with XLH report good health outcomes, for a considerable third much worse outcomes are reported. More research is needed to examine why some experience good and others poor health outcomes and the characteristics which identify them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02620-w","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T06:06:11Z","timestamp":1675836371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK"],"prefix":"10.1186","volume":"18","author":[{"given":"Sophie","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria T.","family":"Sanchez-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Kolovos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-5128","authenticated-orcid":false,"given":"Rafael","family":"Pinedo-Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"7","key":"2620_CR1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, de Beur SMJ, Insogna KL. A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381\u20138.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2620_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","volume":"32","author":"L Seefried","year":"2021","unstructured":"Seefried L, Smyth M, Keen R, Harvengt P. Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review. Osteoporos Int. 2021;32(1):7\u201322.","journal-title":"Osteoporos Int"},{"issue":"3","key":"2620_CR3","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1210\/clinem\/dgz203","volume":"105","author":"S Hawley","year":"2020","unstructured":"Hawley S, Shaw NJ, Delmestri A, Prieto-Alhambra D, Cooper C, Pinedo-Villanueva R, et al. Prevalence and mortality of individuals with X-linked hypophosphatemia: a United Kingdom real-world data analysis. J Clin Endocrinol Metab. 2020;105(3):e871\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2620_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","volume":"3","author":"A Skrinar","year":"2019","unstructured":"Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, et al. The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc. 2019;3(7):1321\u201334.","journal-title":"J Endocr Soc"},{"key":"2620_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/OARRR.S93516","volume":"8","author":"A Sharma","year":"2016","unstructured":"Sharma A, Kudesia P, Shi Q, Gandhi R. Anxiety and depression in patients with osteoarthritis: impact and management challenges. Open Access Rheumatol. 2016;8:103\u201313.","journal-title":"Open Access Rheumatol"},{"issue":"3","key":"2620_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/1756-185X.13098","volume":"21","author":"JH Jung","year":"2018","unstructured":"Jung JH, Seok H, Kim JH, Song GG, Choi SJ. Association between osteoarthritis and mental health in a Korean population: a nationwide study. Int J Rheum Dis. 2018;21(3):611\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2620_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-016-0528-6","volume":"11","author":"MK Javaid","year":"2016","unstructured":"Javaid MK, Forestier-Zhang L, Watts L, Turner A, Ponte C, Teare H, et al. The RUDY study platform\u2014a novel approach to patient driven research in rare musculoskeletal diseases. Orphanet J Rare Dis. 2016;11(1):150.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2620_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"1","key":"2620_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7\u201322.","journal-title":"Health Econ"},{"issue":"5","key":"2620_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B van Hout","year":"2012","unstructured":"van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315.","journal-title":"Value Health"},{"issue":"6","key":"2620_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"4","key":"2620_CR12","first-page":"469","volume":"13","author":"M Grassi","year":"2010","unstructured":"Grassi M, Nucera A. Dimensionality and summary measures of the SF-36 v1.6: comparison of scale- and item-based approach across ECRHS II adults population. Value Health. 2010;13(4):469\u201378.","journal-title":"Value Health"},{"issue":"1","key":"2620_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0022-3999(97)00298-5","volume":"45","author":"JS Carpenter","year":"1998","unstructured":"Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45(1):5\u201313.","journal-title":"J Psychosom Res"},{"issue":"6","key":"2620_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"issue":"2","key":"2620_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symp Manag. 1997;13(2):63\u201374.","journal-title":"J Pain Symp Manag"},{"issue":"10","key":"2620_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"2620_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","volume":"144","author":"RH Dworkin","year":"2009","unstructured":"Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1\u20132):35\u201342.","journal-title":"Pain"},{"issue":"4","key":"2620_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jpain.2015.01.012","volume":"16","author":"RH Dworkin","year":"2015","unstructured":"Dworkin RH, Turk DC, Trudeau JJ, Benson C, Biondi DM, Katz NP, et al. Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain. J Pain. 2015;16(4):357\u201366.","journal-title":"J Pain"},{"issue":"10","key":"2620_CR19","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, T\u00f6lle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911\u201320.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2620_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"6977","key":"2620_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/bmj.310.6977.446","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland JM, Altman DG. Statistics notes: Calculating correlation coefficients with repeated observations: Part 1\u2014correlation within subjects. BMJ. 1995;310(6977):446.","journal-title":"BMJ"},{"issue":"6980","key":"2620_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/bmj.310.6980.633","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 2\u2014correlation between subjects. BMJ. 1995;310(6980):633.","journal-title":"BMJ"},{"key":"2620_CR23","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/ (2020)."},{"key":"2620_CR24","unstructured":"Dowle M, Srinivasan A. data.table: extension of \u2018data.frame\u2019. R package version 1.14.0. https:\/\/CRAN.R-project.org\/package=data.table (2021)."},{"key":"2620_CR25","doi-asserted-by":"crossref","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K. dplyr: a grammar of data manipulation. R package version 1.0.7. https:\/\/CRAN.R-project.org\/package=dplyr (2021).","DOI":"10.1007\/978-1-4842-6876-6_1"},{"key":"2620_CR26","unstructured":"Morton F, Nijjar JS. eq5d: methods for analysing \u2018EQ-5D\u2019 data and calculating \u2018EQ-5D\u2019 index scores. R package version 0.10.0. https:\/\/CRAN.R-project.org\/package=eq5d (2021)."},{"key":"2620_CR27","unstructured":"James D, Hornik K. chron: chronological objects which can handle dates and times. R package version 2.3-56. 2020."},{"key":"2620_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer; 2016."},{"issue":"7","key":"2620_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i07","volume":"45","author":"J Honaker","year":"2011","unstructured":"Honaker J, King G, Blackwell M. Amelia II: a program for missing data. J Stat Softw. 2011;45(7):1\u201347.","journal-title":"J Stat Softw"},{"issue":"3","key":"2620_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Soft. 2011;45(3):1\u201367.","journal-title":"J Stat Soft"},{"issue":"6","key":"2620_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v014.i06","volume":"14","author":"A Zeileis","year":"2005","unstructured":"Zeileis A, Grothendieck G. zoo: S3 infrastructure for regular and irregular time series. J Stat Softw. 2005;14(6):1\u201327. https:\/\/doi.org\/10.18637\/jss.v014.i06.","journal-title":"J Stat Softw"},{"key":"2620_CR32","unstructured":"Wickham H. tidyr: tidy messy data. R package version 1.1.3. https:\/\/CRAN.R-project.org\/package=tidyr (2021)."},{"issue":"7","key":"2620_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v074.i07","volume":"74","author":"A Kowarik","year":"2016","unstructured":"Kowarik A, Templ M. Imputation with the R Package VIM. J Stat Softw. 2016;74(7):1\u201316. https:\/\/doi.org\/10.18637\/jss.v074.i07.","journal-title":"J Stat Softw"},{"key":"2620_CR34","unstructured":"Kassambara A, Mundt F. factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7. https:\/\/CRAN.R-project.org\/package=factoextra (2020)."},{"key":"2620_CR35","unstructured":"Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. cluster: cluster analysis basics and extensions. R package version 2.1.2. 2021."},{"key":"2620_CR36","unstructured":"Bakdash JZ, Marusich LR. rmcorr: repeated measures correlation. R package version 0.4.5. https:\/\/CRAN.R-project.org\/package=rmcorr (2021)."},{"key":"2620_CR37","unstructured":"Wei T, Simko V. R package \u2018corrplot\u2019: visualization of a correlation matrix (Version 0.90). https:\/\/github.com\/taiyun\/corrplot (2021)."},{"key":"2620_CR38","unstructured":"Arnold JB. ggthemes: extra themes, scales and geoms for \u2018ggplot2\u2019. R package version 4.2.4. https:\/\/CRAN.R-project.org\/package=ggthemes (2021)."},{"key":"2620_CR39","unstructured":"Wickham H, Seidel D. scales: scale functions for visualization. R package version 1.1.1. https:\/\/CRAN.R-project.org\/package=scales. 2020."},{"key":"2620_CR40","volume-title":"An R companion to applied regression","author":"J Fox","year":"2019","unstructured":"Fox J, Weisberg S. An R companion to applied regression. 3rd ed. Thousand Oaks: Sage; 2019.","edition":"3"},{"key":"2620_CR41","unstructured":"Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team. _nlme: linear and nonlinear mixed effects models_. R package version 3.1\u2013153. https:\/\/CRAN.R-project.org\/package=nlme (2021)."},{"key":"2620_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-75969-2","volume-title":"Lattice: multivariate data visualization with R","author":"D Sarkar","year":"2008","unstructured":"Sarkar D. Lattice: multivariate data visualization with R. New York: Springer; 2008."},{"issue":"7","key":"2620_CR43","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","volume":"29","author":"SH Lo","year":"2020","unstructured":"Lo SH, Lachmann R, Williams A, Piglowska N, Lloyd AJ. Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2020;29(7):1883\u201393.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"11","key":"2620_CR44","first-page":"4075","volume":"81","author":"MP Whyte","year":"1996","unstructured":"Whyte MP, Schranck FW, Armamento-Villareal R. X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab. 1996;81(11):4075\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2620_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol. 2016;174(3):325\u201333.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2620_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-021-01729-0","volume":"16","author":"E Rodr\u00edguez-Rubio","year":"2021","unstructured":"Rodr\u00edguez-Rubio E, Gil-Pe\u00f1a H, Chocron S, Madariaga L, de la Cerda-Ojeda F, Fern\u00e1ndez-Fern\u00e1ndez M, et al. Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population. Orphanet J Rare Dis. 2021;16(1):104.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2620_CR47","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jval.2018.03.013","volume":"21","author":"I Montan","year":"2018","unstructured":"Montan I, L\u00f6we B, Cella D, Mehnert A, Hinz A. General population norms for the Functional Assessment of Chronic Illness Therapy (FACIT)-fatigue scale. Value Health. 2018;21(11):1313\u201321.","journal-title":"Value Health"},{"issue":"8","key":"2620_CR48","doi-asserted-by":"publisher","first-page":"e0182207","DOI":"10.1371\/journal.pone.0182207","volume":"12","author":"AGM Sch\u00e4fer","year":"2017","unstructured":"Sch\u00e4fer AGM, Joos LJ, Roggemann K, Waldvogel-R\u00f6cker K, Pfingsten M, Petzke F. Pain experiences of patients with musculoskeletal pain + central sensitization: a comparative Group Delphi Study. PLoS ONE. 2017;12(8):e0182207.","journal-title":"PLoS ONE"},{"issue":"1","key":"2620_CR49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13023-022-02452-0","volume":"17","author":"MIL Yanes","year":"2022","unstructured":"Yanes MIL, Diaz-Curiel M, Peris P, Vicente C, Marin S, Ramon-Krauel M, et al. Health-related quality of life of X-linked hypophosphatemia in Spain. Orphanet J Rare Dis. 2022;17(1):298.","journal-title":"Orphanet J Rare Dis"},{"key":"2620_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-94-007-7596-1_3","volume-title":"Self-reported population health: an international perspective based on EQ-5D","author":"B Janssen","year":"2014","unstructured":"Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014. p. 19\u201330."},{"issue":"2","key":"2620_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11136-014-0763-z","volume":"24","author":"S Breeman","year":"2015","unstructured":"Breeman S, Cotton S, Fielding S, Jones GT. Normative data for the Hospital Anxiety and Depression Scale. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2015;24(2):391\u20138.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"10","key":"2620_CR52","doi-asserted-by":"publisher","first-page":"e0139690","DOI":"10.1371\/journal.pone.0139690","volume":"10","author":"E Brodin","year":"2015","unstructured":"Brodin E, Sunnerhagen KS, Baghaei F, T\u00f6rnbom M. Persons with haemophilia in Sweden- experiences and strategies in everyday life: a single centre study. PLoS ONE. 2015;10(10):e0139690.","journal-title":"PLoS ONE"},{"issue":"5","key":"2620_CR53","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10897-016-9941-1","volume":"25","author":"C von der Lippe","year":"2016","unstructured":"von der Lippe C, Frich JC, Harris A, Solbr\u00e6kke KN. Experiences of being heterozygous for fabry disease: a qualitative study. J Genet Couns. 2016;25(5):1085\u201392.","journal-title":"J Genet Couns"},{"issue":"6","key":"2620_CR54","doi-asserted-by":"publisher","first-page":"e2258","DOI":"10.1210\/clinem\/dgac120","volume":"107","author":"TL Spencer","year":"2022","unstructured":"Spencer TL, Watts L, Soni A, Pinedo-Villanueva R, Heegaard AM, Boyce AM, et al. Neuropathic-like pain in fibrous dysplasia\/McCune-albright syndrome. J Clin Endocrinol Metab. 2022;107(6):e2258\u201366.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2620_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bjh.18066","volume":"197","author":"K Ramasamy","year":"2022","unstructured":"Ramasamy K, Sadler R, Jeans S, Weeden P, Varghese S, Turner A, et al. Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response. Br J Haematol. 2022;197(3):293\u2013301.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02620-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02620-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02620-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T06:14:34Z","timestamp":1675836874000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02620-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2620"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02620-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2073986\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the RUDY Study was given from the South Central Research Ethics committee after review (LREC 14\/SC\/0126) in April 2014. An application with detailed analysis plan for this project was submitted and approved by the RUDY Data Access Committee in 2018 and later in September of 2019 to include further patient-reported outcome instruments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MKJ has received research grants from Amgen, Kyowa Kirin Services, and the International Osteoporosis Foundation; speaker fees from Amgen, Besin Healthcare, Sanofi, and Abbvie; and sits in advisory boards for UCB and Kyowa Kirin Services. RPV has received research funding from the UK NIHR, the International Osteoporosis Foundation, Kyowa Kirin Services, Fondation priv\u00e9e des HUG (Geneva, Switzerland), Amgen, and the Royal Osteoporosis Society, and lecture fees and\/or consulting honoraria from Amgen, UCB, Kyowa Kirin Services, Astellas, the International Osteoporosis Foundation, and Mereo Biopharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}